Article Sidebar

pdf
Date Published: 08/10/2025
Abstract Views: 316
Views pdf: 111
DOI: https://doi.org/10.51298/vmj.v554i3.15784
Issue
Vol. 554 No. 3 (2025)
Section
Các bài báo
How to Cite
Hoàng, N. H., Trần, Q. L., Dư, T. N., Nguyễn, H. C., & Nguyễn, Đình M. (2025). DIAGNOSTIC VALUE OF THE PI-QUAL v2 IMAGING QUALITY SCORE ON 3.0T MRI IN THE DETECTION OF PROSTATE CANCER BASED ON PI-RADS v2.1 CLASSIFICATION. Vietnam Medical Journal, 554(3). https://doi.org/10.51298/vmj.v554i3.15784

DIAGNOSTIC VALUE OF THE PI-QUAL v2 IMAGING QUALITY SCORE ON 3.0T MRI IN THE DETECTION OF PROSTATE CANCER BASED ON PI-RADS v2.1 CLASSIFICATION

Ngân Hà Hoàng, Quang Lộc Trần, Thành Nhân Dư, Hữu Chung Nguyễn, Đình Minh Nguyễn

Main Article Content

Abstract

Objective: To evaluate the impact of magnetic resonance imaging (MRI) image quality on the diagnostic performance for prostate cancer (PCa). Materials and Methods: A cross-sectional descriptive study was conducted at Viet Duc University Hospital from September 2019 to June 2025. The study included 124 male patients over 50 years old with suspected prostate cancer. Data collection included clinical examination findings, PSA levels, prostate MRI images, PI-RADS v2.1 scores, and image quality assessment using the PI-QUAL v2 scoring system. Results: The mean age of patients was 69.1 ± 8.3 years. Among the 124 patients, 39 were confirmed to have prostate cancer. The cancer detection rates for PI-RADS 4 and 5 lesions were 77% and 100%, respectively. The diagnostic yield significantly increased with improved image quality based on PI-QUAL v2, particularly in PI-RADS 5 lesions, where the cancer detection rate reached 100%. Conclusion: MRI image quality, as assessed by the PI-QUAL v2 scoring system, has a significant impact on the diagnostic accuracy of prostate cancer using the PI-RADS v2.1 classification

Article Details

Keywords

PIQUAl v2, PIRADS v2.1, prostate cancer, MRI

References

Cuong NC, V.N., Thien NM, Hai PT, Dang TN. Hospital-based prostate cancer screening in vietnamese men with lower urinary tract symptoms: a classification and regression tree model. BMC Urol. 2022;22:166. doi:10.1186/s12894-022-01116-2.
2. Cancer Statistics Review, -.-S.S.A.M., 2024. https://seer.cancer.gov/archive/csr/1975_2015/index.html.
3. Turkbey B, R.A., Haider MA, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019;76(3):340-351. doi:10.1016/j.eururo.2019.02.033.
4. de Rooij M, A.C., Twilt JJ, et al. PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI. Eur Radiol. Published online May 24, 2024. doi:10.1007/s00330-024-10795-4.
5. Pokorny, M.R., et al., Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol, 2014. 66(1): p. 22-9.
6. Fuschi, A., et al., Multiparametric Prostate MRI Accuracy of Prostate Imaging Reporting and Data System (v2.1) Scores 4 and 5: The Influence of Image Quality According to the Prostate Imaging Quality Score. J Clin Med, 2024. 13(13).
7. Brembilla, G., et al., Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy. Eur J Radiol, 2023. 164: p. 110849.
8. Basar, Y., et al., Inter-reader agreement of the prostate imaging quality (PI-QUAL) score for basic readers in prostate MRI: A multi-center study. Eur J Radiol, 2023. 165: p. 110923.